Saranac Partners’s Boston Scientific BSX Stock Holding History

Saranac Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.2M	Buy	95,541 +18,895	+25%	+$1.51M	2.65%	13
2025 Q4	$7.31M	Buy	76,646 +15,629	+26%	+$1.53M	2.86%	14
2025 Q3	$5.95M	Buy	61,017 +5,033	+9%	+$521K	1.08%	23
2025 Q2	$6.01M	Sell	55,984 -1,425	-2%	-$144K	3.19%	9
2025 Q1	$5.79M	Buy	57,409 +3,929	+7%	+$396K	3.29%	11
2024 Q4	$4.78M	Sell	53,480 -2,412	-4%	-$212K	2.64%	16
2024 Q3	$4.68M	Sell	55,892 -4,275	-7%	-$337K	7.07%	10
2024 Q2	$4.63M	Sell	60,167 -6,646	-10%	-$486K	2.75%	17
2024 Q1	$4.58M	Sell	66,813 -7,897	-11%	-$508K	2.8%	17
2023 Q4	$4.32M	Buy	+74,710	New	+$3.99M	2.85%	13

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Saranac Partners's BSX Position: Q1 2026 in Review

Saranac Partners increased its Boston Scientific (BSX) stake by 25% in Q1 2026, buying an estimated $1.51M and bringing the position to 95,541 shares worth $6.2M. The position accounts for 2.65% of the portfolio, ranked #13.

Saranac Partners first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. The position peaked at $7.31M in Q4 2025. 1,673 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Saranac Partners held 95,541 shares of Boston Scientific worth $6.2M as of Q1 2026.
Saranac Partners bought 18,895 Boston Scientific shares in Q1 2026, an estimated $1.51M.
Boston Scientific made up 2.65% of Saranac Partners's portfolio in Q1 2026, its #13 holding.
Saranac Partners first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
Saranac Partners's Boston Scientific position peaked at $7.31M in Q4 2025.
1,673 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Saranac Partners's 13F filing for Q1 2026, filed 15 May 2026.